COV — Covalon Technologies Income Statement
0.000.00%
- CA$63.88m
- CA$47.17m
- CA$31.17m
- 84
- 67
- 87
- 94
Annual income statement for Covalon Technologies, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13.5 | 19.6 | 18.1 | 26.6 | 31.2 |
Cost of Revenue | |||||
Gross Profit | 4.65 | 9.7 | 7.49 | 14.4 | 18.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 20.9 | 18.7 | 27.3 | 31.1 | 28.4 |
Operating Profit | -7.39 | 0.838 | -9.14 | -4.53 | 2.76 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.82 | 0.419 | -9.25 | -4.46 | 2.67 |
Net Income After Taxes | -7.82 | 0.419 | -9.25 | -4.46 | 2.67 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -6.95 | 23.5 | -9.66 | -4.46 | 2.67 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -6.95 | 23.5 | -9.66 | -4.46 | 2.67 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.347 | -0.015 | -0.359 | -0.179 | 0.09 |